| # | Drug | Count |
|---|---|---|
| 0 | ETOPOSIDE | 7 |
| 1 | CYCLOPHOSPHAMIDE | 6 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 6 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 6 |
| 4 | DOXORUBICIN | 5 |
| 5 | VENETOCLAX | 5 |
| 6 | CISPLATIN | 4 |
| 7 | CARFILZOMIB | 3 |
| 8 | DEXAMETHASONE | 3 |
| 9 | DEXAMETHASONE 1.5 MG | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ZONGERTINIB | 1 | 0.0060 |
| 1 | GEMTUZUMAB OZOGAMICIN | 2 | 0.0005 |
| 2 | TOPOTECAN | 2 | 0.0003 |
| 3 | SCOPOLAMINE | 1 | 0.0003 |
| 4 | DRONABINOL | 1 | 0.0001 |
| 5 | POSACONAZOLE | 2 | 0.0001 |
| 6 | CARFILZOMIB | 3 | 0.0001 |
| 7 | ETOPOSIDE | 7 | 0.0001 |
| 8 | TEMOZOLOMIDE | 2 | 0.0001 |
| 9 | VENETOCLAX | 5 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 8 |
| 1 | Topoisomerase Inhibitor [EPC] | 7 |
| 2 | BCL-2 Inhibitor [EPC] | 5 |
| 3 | Corticosteroid [EPC] | 5 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 4 |
| 5 | Platinum-based Drug [EPC] | 4 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 3 |
| 7 | Proteasome Inhibitor [EPC] | 3 |
| 8 | Thalidomide Analog [EPC] | 3 |
| 9 | Azole Antifungal [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD33-directed Immunoconjugate [EPC] | 2 | 0.0005 |
| 1 | Cannabinoid [EPC] | 1 | 0.0001 |
| 2 | Topoisomerase Inhibitor [EPC] | 7 | 0.0001 |
| 3 | BCL-2 Inhibitor [EPC] | 5 | 0.0001 |
| 4 | Anticholinergic [EPC] | 1 | 0.0001 |
| 5 | Recombinant Human Growth Hormone [EPC] | 1 | 0.0000 |
| 6 | Alkylating Drug [EPC] | 8 | 0.0000 |
| 7 | Proteasome Inhibitor [EPC] | 3 | 0.0000 |
| 8 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 1 | 0.0000 |
| 9 | Platinum-based Drug [EPC] | 4 | 0.0000 |